Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes

Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes

Item
http://www.wikidata.org/entity/Q28369082
Drug-induced reactivation of apoptosis abrogates HIV-1 infectionHydroxyurea potentiates the antiherpesvirus activities of purine and pyrimidine nucleoside and nucleoside phosphonate analogsInhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitorsDisparate actions of hydroxyurea in potentiation of purine and pyrimidine 2',3'-dideoxynucleoside activities against replication of human immunodeficiency virusHydroxyurea to inhibit human immunodeficiency virus-1 replication.Strategies to improve efficacy and safety of a novel class of antiviral hyper-activation-limiting therapeutic agents: the VS411 model in [corrected] HIV/AIDSVS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.Antiviral therapy for human immunodeficiency virus infectionsClinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.Antiviral hyperactivation-limiting therapeutics as a novel class for the treatment of HIV/AIDS: focus on VS411.Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptaseThe enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapy.Combination therapy with hydroxyurea versus without hydroxyurea as first line treatment options for antiretroviral-naive patients.
P2860

Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes

Item
http://www.wikidata.org/entity/Q28369082
description
1994 nî lūn-bûn
@nan
1994 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Synergistic anti-human immunod ...... cted resting human lymphocytes
@ast
Synergistic anti-human immunod ...... cted resting human lymphocytes
@en
Synergistic anti-human immunod ...... cted resting human lymphocytes
@nl
type
label
Synergistic anti-human immunod ...... cted resting human lymphocytes
@ast
Synergistic anti-human immunod ...... cted resting human lymphocytes
@en
Synergistic anti-human immunod ...... cted resting human lymphocytes
@nl
prefLabel
Synergistic anti-human immunod ...... cted resting human lymphocytes
@ast
Synergistic anti-human immunod ...... cted resting human lymphocytes
@en
Synergistic anti-human immunod ...... cted resting human lymphocytes
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Synergistic anti-human immunod ...... cted resting human lymphocytes
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932